Viewing Study NCT01336218

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT01336218
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2011-04-14
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None healthy volunteers View
None Rheumatoid arthritis View
None RA View
None Fostamatinib View
None Rifampicin View
None drug-drug interaction View
None Pharmacokinetics View
None Amount of Rifampicin in blood View